Nanoform Finland Investor Relations Material

Nanoform provides nanotechnology and drug particle engineering services for the pharmaceutical industry. The company offers nanoparticle milling, a mechanical fragmentation process that reduces the particle size of APIs and enables the development of more bioavailable formulations. In addition, it provides physical characterization services for nanoparticles that comprises morphological analysis, including atomic force microscopy and scanning electron microscopy; elemental chemical analysis comprising inductively coupled plasma optical emission spectroscopy; and particle size distribution analysis comprising dynamic light scattering and laser diffraction, as well as supporting analytical equipment. The company was founded in 2008 and is headquartered in Helsinki, Finland.